Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1992 Nov;77(3):462–464.

Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (Oligostick).

T J Hall 1, J Brostoff 1
PMCID: PMC1421710  PMID: 1478691

Abstract

We have investigated the ability of an antisense oligonucleotide (ASE-1) to specifically inhibit IgE synthesis by a human myeloma cell line, U266. ASE-1 inhibited IgE production in a concentration-dependent manner, as assessed by isotype-specific ELISA measurement of immunoglobulin in myeloma cell supernatants. Inhibition of IgE production was specific and not due to cytotoxicity since IgG1 and IgM production by human myeloma cell lines ARH-77 and RPMI-1788 respectively, was not significantly affected by up to 20 microM ASE-1 whereas IgE production was inhibited by approximately 70% at this concentration. These results indicate that antisense oligonucleotides represent a potential therapeutic approach to the treatment of IgE-mediated allergic diseases.

Full text

PDF
462

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaser K., Nakagawa T., De Weck A. L. Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice. Immunology. 1983 Mar;48(3):423–431. [PMC free article] [PubMed] [Google Scholar]
  2. Cohen J. S. Designing antisense oligonucleotides as pharmaceutical agents. Trends Pharmacol Sci. 1989 Nov;10(11):435–437. doi: 10.1016/S0165-6147(89)80004-5. [DOI] [PubMed] [Google Scholar]
  3. Gram L. Epileptic seizures and syndromes. Lancet. 1990 Jul 21;336(8708):161–163. doi: 10.1016/0140-6736(90)91672-w. [DOI] [PubMed] [Google Scholar]
  4. Kenten J. H., Molgaard H. V., Houghton M., Derbyshire R. B., Viney J., Bell L. O., Gould H. J. Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6661–6665. doi: 10.1073/pnas.79.21.6661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rabbitts T. H., Forster A., Milstein C. P. Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. Nucleic Acids Res. 1981 Sep 25;9(18):4509–4524. doi: 10.1093/nar/9.18.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sehon A. H. Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. Prog Allergy. 1982;32:161–202. [PubMed] [Google Scholar]
  7. Takahashi N., Ueda S., Obata M., Nikaido T., Nakai S., Honjo T. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell. 1982 Jun;29(2):671–679. doi: 10.1016/0092-8674(82)90183-0. [DOI] [PubMed] [Google Scholar]
  8. Tidd D. M. Synthetic oligonucleotides as therapeutic agents. Br J Cancer. 1991 Jan;63(1):6–8. doi: 10.1038/bjc.1991.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zerial A., Thuong N. T., Hélène C. Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent. Nucleic Acids Res. 1987 Dec 10;15(23):9909–9919. doi: 10.1093/nar/15.23.9909. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES